Cardiovascular Therapy and Prevention, 2016, 15 (4)

Editorial

POLYMORBIDITY: SPECIFICS OF CO-DEVELOPMENT AND CONCOMITANCE OF SEVERAL DISEASES IN ONE PATIENT

Oganov R. G., Drapkina O. M.

National Research Center for Preventive Medicine of the Ministry of Health. Moscow, Russia

Abstract

Originalarticles

Myocardial infarction

ATYPICAL CLINICAL COURSE OF THE ACUTE MYOCARDIAL INFARCTION: CLINICAL AND ANAMNESTIC CHARACTERISTIC OF PATIENTS, MANAGEMENT AND OUTCOMES (DATA FROM REGISTRY OF ACUTE MYOCARDIAL INFARCTION)

Garganeeva А. А.1, Kuzheleva Е. А.1, Borel К. N.1, Parshin Е. А.2

1 RI Cardiology. Tomsk; 2National Research Tomsk Polytechnic University. Tomsk, Russia

Abstract

NOVEL DIRECTION IN MYOCARDIAL INFARCTION PREVENTION — ACCENT ON MEDICAL AND SOCIAL CHARACTERISTICS OF PATIENT

Kireev K. A.1,2, Moskvicheva М. G.2, Fokin А. А.1,2

1 Road Clinical Hospital at Chelyabinsk Station of LLC “RZD”. 2Chelyabinsk; 2South-Ural State Medical University of the Ministry of Health. Chelyabinsk, Russia

Abstract

Chronic heart failure

EVALUATION OF THE ROLE OF HYPERHOMOCYSTEINEMIA AND POLYMORPHISM C677T GENE OF METHYLTETRAHYDROFOLATEREDUCTASE IN DEVELOPMENT OF CHRONIC HEART FAILURE

Teplyakov A. T.1, Berezikova E. N.2, Shilov S. N.2, Grakova E. V.1, Torim Yu. Yu.1, Efremov A. V.2, Popova А . А.2, Pustosvetova М. G.2, Sabirova А. Yu.2, Kopieva К. V.1

1 RI Cardiology. Tomsk, Russia; 2Novosibirsk State Medical University of the Ministry of Health. Novosibirsk, Russia

Abstract

Epidemiology and рrevention

AWARENESS AND TREATMENT SPECIFICS OF STATIN THERAPY IN PERSONS WITH VARIOUS CARDIOVASULAR RISK: THE STUDY ESSE-RF

Shalnova S. A.1, Deev A. D.1, Metelskaya V. A.1, Evstifeeva S. E.1, Rotar O. P.2, Zhernakova Yu. V.3, Boytsov S. A.1 on behalf of ESSE-RF trial workgroup#

1 National Research Center for Preventive Medicine of the Ministry of Health. Moscow; 2Federal Almazov North-West Medical Research Centre of the Ministry of Health. Saint-Petersburg; 3Russian Cardiological Research-and-Production Complex of the Ministry of Health. Moscow, Russia

Abstract

RISK FACTOR PREVALENCE AND PROBABILITY OF FATAL CARDIOVASCULAR EVENTS IN MEN 42-44 YEARS OLD

Aleksandrov А. А.1, Rozanov V. B.1,2, Zvolinskaya Е. Yu.1, Pugoeva Kh. S.1

1 National Research Center for Preventive Medicine of the Ministry of Health. Moscow; 2I.M. Sechenov First Moscow State Medical University of the Ministry of Health. Moscow, Russia

Abstract

AN OBESE PATIENT “PORTRAIT” BY THE RESULTS OF OUTPATIENT CARDIOVASCULAR REGISTRY “PROFILE”

Zakharova A. V., Lukina Yu. V., Voronina V. P., Tolpygina S. N., Kutishenko N. P., Kiseleva N. V., Martsevich S. Yu. on behalf of “PROFILE” registry workgroup#

National Research Center for Preventive Medicine of the Ministry of Health, Moscow, Russia

Abstract

UNHEALTHY DIET AS CARDIOVASCULAR RISK FACTOR IN RURAL POPULATION OF KRASNODARSKI KRAI

Bolotova E. V.1, Komissarova I. M.1,2

1 Kuban State Medical University” of the Ministry of Health. Krasnodar; 2Central District Hospital “Severskaya”. St. Severskaya, Krasnodarski Krai, Russia

Abstract

ANALYSIS OF PREVALENCE OF SELECTED CARDIOVASCULAR RISK FACTORS IN DANGEROUS OCCUPATIONS

Gurevich K. G.1, Arkhangelskaya A. N.1, Pustovalov D. А.1, Anishchenko А. P.1, Burdyukova Е. V.1, Rogoznaya Е. V.2

1 A. I. Evdokimov Moscow State University of Medicine and Dentistry (MSUMD). Moscow; 2Educational-Methodical Training Ground for Novel Educational Technologies PIPEO Pharmaceutical College “New Knowledge”. Moscow, Russia

Abstract

PREVALENCE OF CARDIOVASCULAR RISK FACTORS IN NON-ORGANIZED POPULATION OF 25-64 YEAR OLDS IN TYUMEN REGION. RESULTS OF ESSE-RF STUDY IN TYUMEN REGION

Efanov A. Yu.1,2, Storozhok М. А.1, Sholomov I. F.1,2, Medvedeva I. V.1,2, Shalaev S. V.1

1 Tyumen State Medical University of the Ministry of Health. Tyumen; 2Scientific-Practical Medical Center. Tyumen, Russia

Abstract

REGIONAL SPECIFICS OF CARDIOVASCULAR MORBIDITY AND MORTALITY

Moskvicheva M. G.1, Belova S. А.2, Kremlev S. L.1, Karpova M. I.1, Samsonova N. А.3

1 South-Ural State Medical University of the Ministry of Health. Chelyabinsk; 2Federal Centre of Cardiovascular Surgery of the Ministry of Health. Chelyabinsk; 3Main Bureau of Medical-Social Expertise in Chelyabinskaya Region. Chelyabinsk, Russia

Abstract

Miscellaneous

GENDER SPECIFICS OF SUBFRACTIONAL PLASMA LIPOPROTEIDS DISTRIBUTION

Ozerova I. N., Metelskaya V. A., Gavrilova N. E.

National Research Center for Preventive Medicine of the Ministry of Health. Moscow, Russia

Abstract

Opinionon a problem

DOES THE “OBESITY PARADOX” REALLY TAKE PLACE IN CORONARY HEART DISEASE?

Drapkina O. M., Shepel R. N., Eliashevich S. O.

National Research Center for Preventive Medicine of the Ministry of Health. Moscow, Russia

Abstract

PREDICTIVE VALUE OF CARDIAC CACHEXIA IN CHRONIC HEART FAILURE

Drobysheva E. S., Tokmachev R. E., Budnevsky A. V., Kravchenko A. Ya.

N. N. Burdenko Voronezh State Medical University. Voronezh, Russia

Abstract

A COMPLEX ASSESSMENT OF COMBINATION DRUG THERAPY IN CARDIOVASCULAR COMORBIDITY

Luneva Yu. V.1, Bezuglova E. I.2, Povetkin S. V.1, Kornilov А. А.1

1 Kursk State Medical University of the Ministry of Health. Kursk; 2N. S. Korotkov MHI KCH №1 Kursk, Russia

Abstract

Review

CARDIOPSYCHIATRY. PROBLEMS OF TRANSLATION

Drobizhev M. Yu.1, Kikta S. V.2, Machilskaya O. V.3

1 I.M. Sechenov First Moscow State Medical University of the Ministry of Health. Moscow; 2FSBI Polyclinics № 3 of President’s Protocol Service. Moscow; 3SBHI “N. V. Sklifosofskiy SRI of Urgent Care” of the Department of Health of Moscow, Moscow, Russia

Cardiopsychiatry is relatively new field in medicine that studies psychic disorders (PD) having common pathological pathways with cardiovascular pathology (CVP). Most of them are related to stress and present with disordered neuronal activity. A working classification is proposed for PD in cardiopsychiatry. PD might be caused by: threat from actual CVP (type 1), other threatening situation (type 2a — in persons without CVP, type 2b — if CVP), “causal” non-threatening situation or even not known factors (type 3a — if without CVP, type 3b — with CVP). Literature data suggest that 2a PD does increase (though temporarily) the risk of CVP. Also the 2b PD enforces progression of CVP (possible only in specific pathogenetic variant of disease). Studies of other PD types are demanded. The review includes tables that make visible the

relations of multiple terms used for PD. Information on rational selection of psychotropic drugs is provided.

Key words: cardiopsychiatry, stress, psychic disorders, cardiovascular diseases, psychotropic drugs.

Cardiovascular Therapy and Prevention, 2016; 15(4): 88–97

http://dx.doi.org/10.15829/1728-8800-2016-4-88-97

Яндекс.Метрика